{
  "zip": "112 76",
  "sector": "Healthcare",
  "fullTimeEmployees": 1471,
  "longBusinessSummary": "Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases. The company offers Alprolix for haemophilia B; Doptelet for chemotherapy induced thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. It also develops drug substance for ReFacto AF; BIVV001 for haemophilia A; BIVV0023 for haemophilia B; and Nirsevimab for respiratory syncytial virus. The company operates in Europe, North America, the Middle East, Russia, North Africa, and Asia. It has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.",
  "city": "Solna",
  "phone": "46 86 97 20 00",
  "country": "Sweden",
  "companyOfficers": [],
  "website": "http://www.sobi.com",
  "maxAge": 1,
  "address1": "TomtebodavAegen 23A",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "previousClose": 19.88,
  "regularMarketOpen": 19.88,
  "twoHundredDayAverage": 19.88,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 19.88,
  "navPrice": null,
  "averageDailyVolume10Day": 20,
  "totalAssets": null,
  "regularMarketPreviousClose": 19.88,
  "fiftyDayAverage": 19.88,
  "trailingAnnualDividendRate": null,
  "open": 19.88,
  "averageVolume10days": 20,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.896322,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 19.88,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 20,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 5602164224,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 20,
  "priceToSalesTrailing12Months": null,
  "dayLow": 19.88,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 20,
  "fiftyTwoWeekHigh": 19.88,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 19.88,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 19.88,
  "exchange": "PNK",
  "shortName": "SWEDISH ORPHAN BIOVITRUM AB",
  "longName": "Swedish Orphan Biovitrum AB (publ)",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "BIOVF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_1072270",
  "uuid": "8826a0e2-6b36-3eed-9143-75e8e6c23eb7",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.19929,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 294896992,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.72623,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 183051315,
  "enterpriseValue": 5862548992,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": -0.487,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 19.88,
  "logo_url": "https://logo.clearbit.com/sobi.com"
}